Hamps Bio IPO Details
The Hamps Bio IPO is a fixed price issue with a total issue size of ₹6.22 cr, comprising of fresh issue of 1220000 equity shares. Hamps Bio IPO opened for subscription on Dec 13, 2024 and closed on Dec 17, 2024. Hamps Bio IPO has set the price at ₹51 per share, with a lot size of 2000 shares. Minimum investment for Retail investors was ₹204,000.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on Dec 18, 2024, and listed on both the NSE and BSE on Dec 20, 2024.
Bigshare Services Pvt Ltd has been appointed as the registrar. MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED are the Book Running Lead Manager for the issue.
Before investing in the Hamps Bio IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
- Price Band
- ₹ 51 – 51
- Lot Size
- 2000
- Issue Size
- ₹6.22 Cr
- Minimum Investment
- ₹204000 (4000 Shares)
- Listing Date
- 20 December 2024
Current GMP
₹60 (+117.65%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Hamps Bio Limited
Hamps Bio Limited is a company engaged in the ethical marketing and distribution of pharmaceutical products and the manufacturing of freeze-dried and frozen food products. The company operates under two main divisions: the Pharmaceutical Products Division (Pharma) and the Freeze Dried and Frozen Products (FDFP or FMCG) Division.
Pharmaceutical Products Division
Founded in 2007, Hamps Bio started as an ethical pharmaceutical marketing firm in Gujarat, distributing a variety of pharmaceutical products. These products, such as tablets, syrups, capsules, injectables, and powders, cover a range of therapeutic areas including pediatric care, painkillers, antibiotics, and nutrition supplements. The products are marketed under the brand name “Hamps” and sourced from 16 WHO GMP certified contract manufacturers. The company operates a systematic distribution model, utilizing a network of over 50 distributors and a marketing team that serves approximately 8,000 doctors and medical stores each month, facilitating the sale of 60,000 units. Its main focus is on the domestic market in India, particularly targeting doctors in specialties such as orthopedics, gynecology, dermatology, and surgery.
Freeze Dried and Frozen Products Division (FDFP)
Launched in 2017, this division focuses on the manufacturing of freeze-dried and frozen products, including fruits, vegetables, herbs, and flowers. These products are processed using lyophilization (freeze-drying) technology and are sold both under the brand “FzyEzy” and through contract manufacturing. Hamps Bio’s FDFP products cater to both B2B and B2C business models, supplying industries such as flavor tea, soups, nutrition bars, chocolates, and ice cream, as well as being sold directly to consumers via e-commerce platforms like Amazon and Flipkart. The manufacturing facility in Gujarat is equipped with modern technology and certified with ISO 9001:2015, ISO 22000:2018, FSSAI, and U.S. FDA accreditations.
Hamps Bio has an extensive distribution network, selling its products across 8 Indian states for pharmaceuticals and in 6 countries and 22 states for its freeze-dried food products. The company’s focus on quality control and innovation has allowed it to expand both domestically and internationally.
Hamps Bio IPO Promoters
- Herrik Shah
- Shrenik Shah
- Pallavi Shah
- Mitali Shah
- Herrik Shah HUF
- Shrenik Shah HUF
Promoters Holding
Holding Pre Issue
100.00%
Holding Post Issue
71.99%
Hamps Bio IPO Objective
The Company intends to use its proceeds as follows:
- Purchase of plant & machinery for FMCG division
- Enhancing the visibility and awareness of the brand
- General corporate purposes
Address / Contact Info
Hamps Bio Limited
2900/112, GIDC, Near
Atul Limited, Ankelshwar
Bharuch – 393 002
Gujarat
Phone: +91 8000006663
Email: info@hampsbio.com
Website: http://www.hampsbio.com
IPO Snapshot
Book Running Lead Managers
- MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Hamps Bio IPO is a Fixed price IPO with a total issue size of ₹6.22 crore. The Hamps Bio IPO price band is ₹51 to 51 per share. The Hamps Bio IPO subscription opens on Fri, Dec 13, 2024, and closes on Tue, Dec 17, 2024. The Hamps Bio IPO will be listed on the BSE. Bigshare Services Pvt Ltd is the registrar for the Hamps Bio IPO.
The Hamps Bio IPO opens on Fri, Dec 13, 2024 and closes on Tue, Dec 17, 2024
Hamps Bio IPO Price Band is ₹51 to 51 per share.
Hamps Bio IPO lot size is 2000 shares, Retail investors need a minimum investment of ₹204000 based on the upper price band
The minimum investment for Hamps Bio IPO is ₹204000, based on one lot of 2000 shares at the upper price band of ₹51 per share.
Investors can apply for the Hamps Bio IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Tue, Dec 17, 2024. The application amount remains blocked until the Hamps Bio IPO allotment is finalized.
Hamps Bio IPO issue size is ₹6.22 crores.
Hamps Bio IPO allotment date is Wed, Jul 1, 2026.
The registrar for Hamps Bio IPO is Bigshare Services Pvt Ltd. Investors can go to Bigshare Services Pvt Ltd website to check Hamps Bio IPO allotment status, refund processing, and other IPO-related information.
The Hamps Bio IPO GMP (Grey Market Premium) is ₹60 as of Fri, Dec 20, 2024. Based on the upper price band of ₹51 per share, the estimated Hamps Bio IPO listing price is ₹111, indicating a potential listing gain of approximately 0% over the issue price.